Evidence map›Paper›PMID 17921094›Full record

ReviewCancer imaging : the official publication of the International Cancer Imaging Society2007

The indeterminate adrenal mass in patients with cancer.

A Sahdev, R H Reznek

Abstract readReview
In one paragraph

Review in Cancer imaging : the official publication of the International Cancer Imaging Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Adrenal myelolipoma with severe hemorrhage: a case report.Journal of surgical case reports · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Radiographic Characteristics of Adrenal Masses in Oncologic Patients.Endocrinology and metabolism (Seoul, Korea) · 2016
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A SahdevDepartment of Radiology, St Bartholomew's Hospital, Dominion House, 59 Bartholomew's Close, London, EC1A 7ED, UK. anju.sahdev@bartsandthelondon.nhs.uk
R H Reznek

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the increasing use of abdominal cross-sectional imaging, incidental adrenal masses are frequently detected. The commonest clinical question is whether these are benign adenomas or malignant primary or secondary masses. The nature of incidentally detected adrenal masses can be determined with a high degree of accuracy using computed tomography (CT) and magnetic resonance imaging (MRI) as benign adrenal masses such as myelolipomas, lipid-rich adenomas, adrenal cysts and adrenal haemorrhage which have pathognomonic imaging findings. However, there remains a significant overlap between the imaging features of some lipid-poor adenomas and malignant lesions. We review the recent advances in CT, MRI and positron emission tomography (PET) which can be used to distinguish between benign adenomas and malignant lesions of the adrenal gland.

Indexed as

Adrenal Gland DiseasesAdrenal Gland NeoplasmsContrast MediaDiagnosis, DifferentialHumansIncidental FindingsMagnetic Resonance ImagingNeoplasmsRadiopharmaceuticalsTomography, Emission-ComputedTomography, X-Ray ComputedContrast MediaRadiopharmaceuticals

Identifiers

PMID17921094
PMCPMC2727974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.